• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W.L. GORE & ASSOCIATES GORE® VIABAHN® ENDOPROSTHESIS; NIP

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W.L. GORE & ASSOCIATES GORE® VIABAHN® ENDOPROSTHESIS; NIP Back to Search Results
Device Problem Improper or Incorrect Procedure or Method (2017)
Patient Problems Ischemia (1942); Pain (1994)
Event Type  Injury  
Manufacturer Narrative
(b)(4).Device lot number information was requested, but not made available.Therefore, no review of the manufacturing paperwork could be performed.The device remains implanted.Therefore, direct product analysis was not possible.Instructions for use warnings states, w.L.Gore & associates has insufficient clinical and experimental data upon which to base any conclusions regarding the effectiveness of the gore® viabahn® endoprosthesis in applications other than the endovascular grafting of superficial femoral, iliac arteries or the venous anastomosis of the arteriovenous (av) access circuit.Special care should be taken to ensure that the appropriate size endoprosthesis, compatible sheath and guidewire are selected prior to introduction.Native vessel dimensions must be accurately measured, not estimated.Sizing table states, recommended endoprosthesis compression within the vessel is approximately 5 ¿ 20%.
 
Event Description
Reviewed was publication, "common femoral vein stent placement in a frozen abdomen causing acute limb ischemia", authors kathleen m.Lamb, md, julia glaser, md, phillip dowzicky, md, and paul j.Foley, md, philadelphia, pa.(j vasc surg cases and innovative techniques 2017;3:63-5.) a patient with a history of metastatic anal carcinoma was admitted for left groin hemorrhage and an acute drop in hemoglobin level at the site of a fungating tumor of perianal squamous cell carcinoma.The patient previously had chemotherapy treatment and had received palliative pelvic irradiation in the left leg.Computed tomography (ct) scan showed the femoral vein was the source of the bleeding.From the left popliteal vein, a 12f sheath was used to place a 13x5 gore® viabahn® endoprosthesis at the left distal external iliac/common femoral vein.As reported, the vein measured 7.4 mm before placement of a 13mm device.A 12mm angioplasty balloon was used for post dilation.The hemorrhage stopped with the device placement.On completion venography, thrombus was noted in the common femoral vein, requiring angiojet and percutaneous thrombectomy of the common iliac vein.Immediately after the procedure, the patient had left leg pain and decreased sensation in the foot.Ct angiography revealed patent vessels, but mass effect on the left external iliac and common femoral arteries from the left common femoral vein stent.The patient was heparinized and taken to the operating room.Through the right common iliac artery access, diagnostic arteriography revealed stenosis of the left common iliac and external iliac arteries.A 7x10 gore® viabahn® endoprosthesis was placed into the left external iliac artery.It was stated the patient¿s lower extremity compartments remained soft after revascularization.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE® VIABAHN® ENDOPROSTHESIS
Type of Device
NIP
Manufacturer (Section D)
W.L. GORE & ASSOCIATES
flagstaff AZ
Manufacturer (Section G)
MEDICAL ECHO RIDGE B/P
3250 w. kiltie lane
flagstaff AZ 86005
Manufacturer Contact
genevieve begay
1500 n. 4th street
flagstaff, AZ 
9285263030
MDR Report Key6950266
MDR Text Key89342805
Report Number2017233-2017-00538
Device Sequence Number1
Product Code PFV
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P040037
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,study
Reporter Occupation Physician
Type of Report Initial
Report Date 09/15/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received Not provided
Initial Date FDA Received10/13/2017
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age73 YR
-
-